Protection Against Tauopathy by the Drug Candidates NAP (Davunetide) and D-SAL: Biochemical, Cellular and Behavioral Aspects

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|25|2603-2612

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.25, 2011-08, pp. : 2603-2612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAP (Davunetide) Provides Functional and Structural Neuroprotection

By  

Current Pharmaceutical Design, Vol. 17, Iss. 10, 2011-04 ,pp. : 1040-1044

Bentham Science Publishers

Access to resources Recommend Favorite

Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)

By  

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3413-3417

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamine-induced amnesia

By Nagpal Kalpana   Singh S. K.   Mishra D. N.  

Drug Delivery, Vol. 20, Iss. 3-4, 2013-04 ,pp. : 112-119

Informa Healthcare

Access to resources Recommend Favorite

Genetic and Biochemical Aspects of Drug Resistance in Malaria Parasites

By  

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling Studies of Peptide Drug Candidates against SARS

By  

Medicinal Chemistry, Vol. 2, Iss. 3, 2006-05 ,pp. : 309-314

Bentham Science Publishers

Access to resources Recommend Favorite